Although lifestyle modification remains a key component of hypertension management in the presence of insulin resistance, when insulin resistance is confirmed and this type of intervention is not sufficient, insulin-sensitizing substances should be used in association with common antihypertensive pharmacologic treatments, such as RAAS blockade with ACE inhibitors or angiotensin receptor blockers. The gene discussed is INS; the disease is Insulin resistance.